Gianluca Iacobellis MD PhD
Diabetes, Lipid Metabolism, Obesity
Full Professor, Medicine, University of Miami Leonard M. Miller School of Medicine
Join to View Full Profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-4000
Dr. Iacobellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My clinical activity focuses on the contemporary treatment and prevention of diabetes and diabetes related cardiovascular complications.
My research pioneered the role of epicardial fat as new cardiovascular risk factor and therapeutic target.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2005
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2004 - 2005
Sapienza University of RomeClass of 1994, MD, 110/110 cum laude
Certifications & Licensure
FL State Medical License 2010 - 2026
Awards, Honors, & Recognition
- Office of Research, Research Education and Innovative Medicine University of Miami, 2017
- Internal Career Award McMaster University, 2006
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Liraglutide Hospital Discharge Trial Start of enrollment: 2014 Mar 01
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes Start of enrollment: 2014 Mar 01
- Dapagliflozin Effects on Epicardial Fat Start of enrollment: 2015 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsComparison of Glycemic Control Between In-Person and Virtual Diabetes Consults in Hospitalized Patients With Diabetes.Maria Gracia Luzuriaga, Monica Lieberman, Ruixuan Ma, Sabina Casula, Violet Lagari-Libhaber
Journal of Diabetes Science and Technology. 2025-03-01 - 1 citationsLiraglutide effects on epicardial adipose tissue micro-RNAs and intra-operative glucose control.Gianluca Iacobellis, Jeffrey J Goldberger, Joseph Lamelas, Claudia A Martinez, Carlos Munoz Sterling
Nutrition, Metabolism, and Cardiovascular Diseases. 2025-02-01 - Epicardial adipose tissue, cardiac damage, and mortality in patients undergoing TAVR for aortic stenosis.Pamela Piña, Daniel Lorenzatti, Annalisa Filtz, Andrea Scotti, Elena Virosta Gil
The International Journal of Cardiovascular Imaging. 2025-02-01
Press Mentions
Night Owls May Be at Greater Risk for T2D, Beyond LifestyleSeptember 11th, 2024- AI Voice Analysis for Diabetes Screening Shows PromiseSeptember 11th, 2024
- NIH Grant Supports Innovative Multifaceted Heart StudyApril 27th, 2021
- Join now to see all
Grant Support
- Liraglutide effects on epicardial fat inflammatory genes in diabetes and coronary artery diseaseNovo Nordisk2018–Present
- Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 DiabetesAstra Zeneca2015–Present
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesNovo Nordisk2014–Present
- Trans-omic analysis of epicardial adipose tissue in atrial fibrillationNIH2019–2023
- Liragultide effects on Atrial Fibrillation (LEAF)NIH2019–2022
Other Languages
- Italian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
